TELA Bio Launches Innovative Hernia Repair Device in the U.S. Market

2d ago, source: MyChesCo on MSN

TELA Bio, Inc. (NASDAQ: TELA), a leading innovator in the medical device sector, announced this week the U.S. launch of its ...

TELA Bio, Inc. (TELA) Q4 2023 Earnings Call Transcript

29d ago, source: Seeking Alpha

Good afternoon ladies and gentlemen and welcome to the TELA Bio Fourth Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer ...

TELA Bio announces US launch OviTex IHR for use in laparoscopic and robotic-assisted inguinal hernia repair

3d ago, source: Pharmabiz

Malvern, Pennsylvania Tuesday, April 16, 2024, 14:00 Hrs [IST] ...

TELA Bio, Inc. (TELA) Reports Q4 Loss, Tops Revenue Estimates

29d ago, source: Nasdaq

TELA Bio, Inc. (TELA) came out with a quarterly loss of $0.53 per share versus the Zacks Consensus Estimate of a loss of $0.44. This compares to loss of $0.52 per share a year ago. These figures ...

TELA Bio Inc Ordinary Shares TELA

3d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

TELA Bio Announces Sale of Distribution Rights for Wound Care Product to MIMEDX

1mon ago, source: Nasdaq

MALVERN, Pa., March 20, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions ...

TELA Bio Achieves Record Fourth Quarter and Full Year 2023 Revenues and Reports Complete Financial Results

29d ago, source: Business Insider

MALVERN, Pa., March 21, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions ...

TELA Bio Welcomes Acclaimed Surgeon as Vice President of Medical Affairs and Surgeon Strategy

11d ago, source:

In his role, Dr. Langstein will be utilizing his expertise to share the clinical benefits of the OviTex ® Reinforced Tissue Matrix portfolio with surgeons and hospital administrators and to aid in ...

TELA Bio, Inc. (NASDAQ:TELA) Q4 2023 Earnings Call Transcript

28d ago, source: Insider Monkey

TELA Bio, Inc. misses on earnings expectations. Reported EPS is $-0.53 EPS, expectations were $-0.44. TELA isn’t one of the 30 most popular stocks among hedge funds at the end of the third ...

TELA Bio, Inc. (NASDAQ:TELA) Q4 2023 Earnings Call Transcript

29d ago, source: Yahoo Finance

TELA Bio, Inc. (NASDAQ:TELA) Q4 2023 Earnings Call Transcript March 21, 2024 TELA Bio, Inc. misses on earnings expectations. Reported EPS is $-0.53 EPS, expectations were $-0.44. TELA isn't one of ...